Adolore BioTherapeutics Announces FDA Orphan Drug Designation for its Kv7-activating rdHSV-CA8* Therapy in the Treatment of Erythromelalgia

Orphan Drug Designation applies to approximately 50,000 Patients who predominantly suffer from severe chronic pain due to ...

Adolore Biotherapeutics, Inc.: Adolore BioTherapeutics Announces FDA Orphan Drug Designation for its Kv7-activating rdHSV-CA8* Therapy in the Treatment of Erythromelalgia

Orphan Drug Designation applies to approximately 50,000 Patients who predominantly suffer from severe chronic pain due to hereditary neuronal sodium ion channel mutationsAdolore's Kv7 voltage-gated po ...
Tsuki on MSN

When invasive animals crossed from disruption to murder

Invasive species often arrive without drawing attention, slowly integrating into new environments. In some cases, that ...
Tyler Nolan on MSN

Why a sudden rat surge became a major problem

A rat infestation has emerged at the ranch, creating immediate risks for animals, facilities, and biosecurity. Rodents can ...